The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13)

Autism

Rethinking Measurement Standards of Autism Symptomology in Adolescents with Fragile X Syndrome

J Autism Dev Disord

Fielding-Gebhardt H, Bredin-Oja SL, Warren SF, Brady NC

doi: 10.1007/s10803-021-04892-2

Autism

Development of White Matter Circuitry in Infants With Fragile X Syndrome

JAMA Psychiatry.

Swanson MR, Wolff JJ, Shen MD, Styner M, Estes A, Gerig G, McKinstry RC, Botteron KN, Piven J, Hazlett HC; Infant Brain Imaging Study (IBIS) Network

doi: 10.1001/

Aging and Cognitive FunctionsAutism

The autism spectrum phenotype in ADNP syndrome

Autism Res.

Arnett AB, Rhoads CL, Hoekzema K, Turner TN, Gerdts J, Wallace AS, Bedrosian-Sermone S, Eichler EE, Bernier RA

doi: 10.1002/aur.1980.

Psychosis and Schizophrenia

Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size

Mol Psychiatry.

Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, Jalbrzikowski M, Hansen L, Villalon-Reina JE, Qu X, Jonas RK, van Amelsvoort T, Bakker G, Kates WR, Antshel KM, Fremont W, Campbell LE, McCabe KL, Daly E, Gudbrandsen M, Murphy CM, Murphy D, Craig M, Vorstman J, Fiksinski A, Koops S, Ruparel K, Roalf DR, Gur RE, Schmitt JE, Simon TJ, Goodrich-Hunsaker NJ, Durdle CA, Bassett AS, Chow EWC, Butcher NJ, Vila-Rodriguez F, Doherty J, Cunningham A, van den Bree MBM, Linden DEJ, Moss H, Owen MJ, Murphy KC, McDonald-McGinn DM, Emanuel B, van Erp TGM, Turner JA, Thompson PM, Bearden CE

doi: 10.1038/s41380-018-0078-5.

Autism

A non randomized mentalization intervention for parents of children with autism

Autism Res.

Enav Y, Erhard-Weiss D, Kopelman M, Samson AC, Mehta S, Gross JJ, Hardan AY

doi: 10.1002/aur.

AutismPsychosis and Schizophrenia

Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study

JAMA Psychiatry.

Hoeffding LK, Trabjerg BB, Olsen L, Mazin W, Sparsø T, Vangkilde A, Mortensen PB, Pedersen CB, Werge T

doi: 10.1001/

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

COMMENTED

Aging and Cognitive Functions

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

JAMA Neurol.

Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K

doi: 10.1001/jamaneurol.

EpilepsyParkinson’s DiseaseAnxiety and DepressionAutismPsychosis and SchizophreniaAttention Deficit Hyperactivity Disorder (ADHD)

Neurobiological perspective of 22q11.2 deletion syndrome

Lancet Psychiatry.

Zinkstok JR, Boot E, Bassett AS, Hiroi N, Butcher NJ, Vingerhoets C, Vorstman JAS, van Amelsvoort TAMJ

doi: 10.1016/S2215-0366(19)30076-8.

Related content

Rethinking Measurement Standards of Autism Symptomology in Adolescents with Fragile X Syndrome

Development of White Matter Circuitry in Infants With Fragile X Syndrome

The autism spectrum phenotype in ADNP syndrome

Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size

A non randomized mentalization intervention for parents of children with autism

Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study

Vaccination Readiness in Multiple Sclerosis

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

Neurobiological perspective of 22q11.2 deletion syndrome